Read More Analyst Ratings Downgrades News Price Target Goldman Sachs Downgrades PagSeguro Digital to Sell, Lowers Price Target to $9 By Benzinga Newsdesk December 1, 5:52 AM Goldman Sachs analyst Tito Labarta downgrades PagSeguro Digital (NYSE:PAGS) from Neutral to Sell and lowers the price target from $15 to $9. PAGS
Read More FDA News FDA Approved KEYTRUDA For Treatment Of Patients With Resectable (T≥4 cm or N+) NSCLC In Combination With Chemotherapy As Neoadjuvant Treatment, Then Continued As A Single Agent As Adjuvant Treatment After Surgery By Charles Gross October 16, 7:02 PM Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, for the treatment of MRK
Read More Analyst Ratings News Price Target Cowen & Co. Maintains Outperform on Shoals Technologies Gr, Lowers Price Target to $35 By Benzinga Newsdesk January 20, 9:10 AM Cowen & Co. analyst Jeffrey Osborne maintains Shoals Technologies Gr (NASDAQ:SHLS) with a Outperform and lowers the price target from $37.5 to $35. SHLS
Read More News 5 Value Stocks To Watch In The Communication Services Sector By Benzinga Insights November 27, 10:44 AM What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices… GDC